Neuroscience
Antipsychotic
72%
DOPA
34%
Treatment-Resistant Schizophrenia
30%
Negative Syndrome
29%
positron emission tomographic scan
29%
Dopaminergic
25%
Disorientation
24%
Depressive Psychosis
24%
Striatum
21%
Cognitive Disorders
20%
Glutamic Acid
19%
Predictor
18%
Bipolar Disorder
18%
Bipolar Mania
18%
Fluorine-18
18%
Hallucination
18%
Schizoaffective Disorder
18%
Temporal Lobe
16%
Affective Psychosis
16%
Clozapine
13%
Cognitive Function
12%
Neuroscience
12%
Thought Disorder
11%
Neurotransmitter
10%
Frontal Lobe
10%
Nuclear Magnetic Resonance Spectroscopy
9%
Positron Emission Tomography
9%
Natural Language Processing
9%
Organizational Structure
9%
Delusion
9%
Longitudinal Study
9%
Auditory Hallucination
9%
Gyrification
9%
Neuropsychological Test
7%
Positive Syndrome
7%
Psychology
Schizophrenia
100%
Psychotic Disorder
39%
Disorientation
36%
Factor Analysis
20%
Bipolar Disorder
18%
Delusion
18%
Regression Analysis
17%
Cognitive Performance
14%
Neuropsychological Deficit
11%
Bipolar Mania
11%
Cognitive Function
11%
Schizoaffective Disorder
11%
Hallucinations
10%
Thought Disorder
10%
Depressive Disorder
9%
Mental State
9%
Major Depression
9%
Gender Difference
9%
Demographic Characteristic
9%
Early Intervention
9%
Cognitive Deficit
9%
Demographic Factor
9%
Cognitive Functioning
9%
Cross-Validation
9%
Processing Speed
9%
Clinical Utility
9%
Longitudinal Analysis
9%
Hierarchical Model
9%
Body Mass Index
9%
Cognitive Impairment
7%
Regression Model
6%
Medicine and Dentistry
Negative Syndrome
22%
Diseases
19%
Fluorine-18
18%
DOPA
18%
Affective Psychosis
16%
Hallucination
13%
Effect Size
12%
Delusion
11%
Positron Emission Tomography
11%
Prevalence
10%
Antipsychotic
9%
Test Retest Reliability
9%
Auditory Hallucination
9%
Dopamine Metabolism
9%
Cross Sectional Study
9%
Depressive Disorder
9%
Thought Disorder
9%
Cariprazine
9%
Treatment-Resistant Schizophrenia
9%
Disorientation
8%
Odds Ratio
6%
Symptomatology
6%